THURSDAY, Sept. 15 (HealthDay News) -- As Europe struggles to combat increasing rates of drug-resistant tuberculosis, health officials say the disease is less of a threat in North America -- at least so far.
But, they add, the ease of travel that's a hallmark of the modern world means no one should think they're beyond risk.
"Drug-resistant TB exists all over the world," said Dr. Mel Spigelman, president and CEO of the Global Alliance for TB Drug Development, a nonprofit group working to combat the infectious respiratory disease.
In the United States, most tuberculosis cases come from immigrants or visitors from other countries, Spigelman said, adding, "This highlights that we are in a mobile world and drug-resistant TB is spreading."
On Tuesday, the World Health Organization unveiled a plan to combat the disease in Europe, which is home to nine countries with the world's highest rates of new drug-resistant TB cases, including Azerbaijan, Moldova, Russia and Ukraine, the Associated Press reported.
The goal of the $5 billion WHO plan is to diagnose 85 percent of all patients and to treat at least 75 percent of them by the end of 2015, resulting -- it is hoped -- in 120,000 lives saved. Presently, only 32 percent of patients with drug-resistant TB in western Europe are properly treated. One of the problems: many patients stop taking their medicines before the end of recommended treatment, leading to drug resistance.
Officials are trying to combat two particularly worrisome forms of the disease -- multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
Although the full extent of the problem in Europe isn't clear, officially reported numbers show a sixfold increase of extensively drug-resistant TB between 2008 and 2009.
And western Europe is far from immune. London, for example, has the highest TB rate of any capital
'/>"/>
| Copyright©2010 ScoutNews,LLC. All rights reserved |